NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/10/2024
Back to search
Official data from USPTO
GENETAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
12/10/2024
Trademark type
Word
Nice classes
5, 42
Filing date
10/19/2020
Registration date
12/10/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/10/2024
Last transaction
12/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/05/2024
First use in commerce
08/05/2024
Drawing code
4
Owner type
03
Owner location
Carlsbad, CA, US
Examiner
KUHN, RIO
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Design Therapeutics, Inc.
Representatives
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of degenerative disorders and diseasesgenetic disorders and diseasesdisorders and diseases caused by transcriptional dysregulation; therapeutic pharmaceuticals for the treatment of degenerative disorders and diseasesgenetic disorders and diseasesdisorders and diseases caused by transcriptional dysregulation; small molecule therapies for the treatment of degenerative disorders and diseasesgenetic disorders and diseasesdisorders and diseases caused by transcriptional dysregulationall of the foregoing related to therapies that target nucleic acids and modulate gene expression
Class 42
pharmaceutical research and products development for the treatment of degenerative disorders and diseasesgenetic disorders and diseasesdisorders and diseases caused by transcriptional dysregulation; research and development of therapeutics for the treatment of degenerative disorders and diseasesgenetic disorders and diseasesdisorders and diseases caused by transcriptional dysregulation; research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseasesgenetic disorders and diseasesdisorders and diseases caused by transcriptional dysregulation; medical and scientific research in the field of pharmaceuticalsall of the foregoing related to therapies that target nucleic acids and modulate gene expression
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/10/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/18/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/18/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/12/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/12/2024
IUAF
USE AMENDMENT FILED
09/10/2024
EISU
TEAS STATEMENT OF USE RECEIVED
09/10/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/30/2024
EX2G
SOU EXTENSION 2 GRANTED
04/29/2024
EXT2
SOU EXTENSION 2 FILED
04/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/24/2023
EX1G
SOU EXTENSION 1 GRANTED
10/20/2023
EXT1
SOU EXTENSION 1 FILED
10/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/20/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/21/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/21/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/21/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/21/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/21/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/02/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
03/20/2023
OP.T
OPPOSITION TERMINATED NO. 999999
03/20/2023
OP.D
OPPOSITION DISMISSED NO. 999999
03/20/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
10/28/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2021
DOCK
ASSIGNED TO EXAMINER
03/18/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/07/2020
NWAP
NEW APPLICATION ENTERED
10/22/2020
Continuous trademark protection
Get notified about every new filing that threatens GENETAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.